Side-by-side comparison of AI visibility scores, market position, and capabilities
Platform automating Kubernetes-based development and testing workflows to give developers fast, production-like environments.
Garden is a Berlin-based developer platform that provides engineering teams with automated, reproducible development and testing environments that closely mirror production. Garden's orchestration engine manages the full lifecycle of a Kubernetes-based application stack — building containers, deploying services, running integration tests, and syncing code changes — based on a declarative project description. Engineers benefit from shared remote build caches that make environment startup fast and consistent test environments that eliminate "it failed in CI but not locally" scenarios. Garden is particularly valuable for teams running complex microservices stacks where spinning up a full local environment is impractical. The platform integrates with GitHub Actions and other CI systems to provide ephemeral preview environments per pull request, enabling faster code review cycles. Founded in 2018, Garden raised over $25M from investors including Accel and Nauta Capital. It competes with Tilt, Skaffold, and Okteto in the Kubernetes developer environment market.
Adept AI raised $415M to pioneer computer-use AI agents; its core research and agent team moved to Amazon in 2024 in a landmark talent acquisition while the company continues developing ACT-1 for enterprise automation.
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and executing multi-step workflows in any application. Its ACT-1 model demonstrated the ability to control web browsers and desktop applications through natural language instructions, pioneering the computer-use agent paradigm that Anthropic later commercialized with Claude's computer use feature.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.